Defymed
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes (NCT05221359) | Defymed | 2022-05-05 |
Track Defymed automatically
Every clearance here is in the API, with alerts when new ones post.